1. K-State home
  2. »College of Veterinary Medicine
  3. »Research
  4. »Midwest Institute for Comparative Stem Cell Biology
  5. »Funding

College of Veterinary Medicine


The Kansas State Legislature has appropriated funding that supports many ongoing stem cell-related research projects. In addition, examples of other funding sources are listed below.

NSF DMR – 1242765 Dual PI (Stefan Bossmann and Deryl Troyer)
CREATIV: Neutrophil delivery of apoptosis-inducing drugs.

NSF CBET 1159966 Dual PI (Stefan Bossmann and Deryl Troyer)
Extending the luminescence lifetime in breast cancer diagnostics

NSF-CBET 933701 Dual PI (Stefan Bossmann and Deryl Troyer): Renilla Transfected stem cells as light source for In-Situ Photodynamic Therapy of Cancer. 1/01/10-12/31/12

NIH CHHSN26100800059C Phase II from the Small Business Innovation Research Development Center (SBIR) of the National Cancer Institute. Kroh F, NanoScale Corp., PI; Bossmann S Co-PI, Troyer D, Co-PI, Gadbury G, Co-PI. Low-Toxicity Nanomaterials for treatment and detection of cancer. 01/01/11-12/31/12

USDA Davis D (PI), Troyer D (Co-PI), Grieger D (Co-PI): "Stem cells and pluripotency in farm animals" USDA HATCH #KS413, 10/01/08-9/30/13.

Legislative Appropriation Troyer D (PI), Davis D (PI), Weiss M (PI): Postnatal stem cells derived from Wharton's Jelly of the umbilical cord. Kansas State Legislative Appropriation, 7/1/06-present.

Previously funded

Bioscience Authority (Collaborative Cancer Research Initiative; CCRI). Tamura M (PI); Troyer D (Co-PI); Weiss M (Collaborator); Marini F (Collaborator): Umbilical cord matrix stem cell-based gene therapy for pancreatic cancer. 12/31/09-12/30/11.

NIH P20 RRO16475 Troyer D, PI
Novel paradigm using monocytes with magnetic nanoparticles and Sn-38 in melanoma. 5/01/2010-4/30/2012.

NSF STTR Bossman S (PI), Chikan V (Co-PI), Troyer D (Co-PI): Intelligent low toxicity materials for cancer diagnosis and treatment. NanoScale Coporation (NSF phase I STTR and Kansas Bioscience Authority flowdown) 7/01-09-6/30/10.

NIH COBRE Tamura M (PI), Troyer D (Co-Invest), Nanoparticle-based dual gene therapy for lung adenocarcinoma. NIH P20 RR015563,National Center for Research Resources, University of Kansas Experimental Therapeutics COBRE, 10/01/08-9/30/2010

NIH R21 Troyer D (PI), Tamura M (Co-Invest), Hua D (Co-Invest): Stem cells as vehicles for therapeutic nanoparticle delivery to breast cancer. NIH 1R21CA135599. 5/1/2008-4/30/2010